
Feature|Events|September 3, 2026
- BioPharm International September October 2026
- Volume 39
- Issue 5
Holding the Line: Why Differential Pressure Is Critical in GMP Cleanrooms
Author(s)Eric Bankos
Fact checked by: Ron Panarotti
GMP cleanroom differential pressure control prevents FDA 483 citations and contamination failures through HVAC design and validation.
Advertisement
Advertisement
In today’s high‑stakes world of pharmaceutical and biotech
Related to this article

Final FDA guidance replaces 2011 potency testing advice, asking CGT makers to build potency assurance from IND filing through postmarket monitoring.

CAR-T transformed blood cancer care, but solid and brain tumors demand different delivery, manufacturing, and safety strategies to work.

Industry experts discuss how reshoring, fill/finish capacity, and cold chain technology are shaping a more resilient biopharma supply chain.

Matt Trupo, Richard Jaenisch, and Brian Drapeau explore how AI advances biological insights, drug-target discovery, and supply chains.

As access to low Earth orbit expands, space-based research is opening possibilities in drug discovery, formulation, and manufacturing. In Part 1, the authors look at how microgravity changes biology and chemistry in ways that can’t be reproduced on Earth and where it fits from target discovery to life cycle management.

Aldevron and IDT added PE Ultra prime editor mRNA and 6 ABE8e base editor mRNAs to help researchers edit DNA without double-strand breaks.

Shilpa CDMO's $50 million plan adds 10 kL of SPPS reactor capacity in Raichur, India, with its first commercial peptide line opening in December 2026.
Advertisement
Advertisement

